Influenza A Infection Increases Severity of Acute Ischemic Stroke Through Neutrophil Activation and Hypercoagulability
Authors:
- 1 December 2025
- journal article
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (12) , 3500-3511
Abstract
BACKGROUND: Respiratory viruses, such as influenza viruses and SARS-CoV-2, cause severe infections of the respiratory system. Cohort studies and clinical observations indicate that patients with severe influenza A virus (IAV) infections are at an increased risk of developing an ischemic stroke event. However, the underlying mechanisms remain elusive. To this end, we investigated the consequences of IAV infection on cerebral damage in a mouse model of ischemic stroke. METHODS: We intranasally inoculated male C57BL6/N mice with the mouse-adapted IAV strain A/Puerto Rico 8/34 or PBS as a vehicle control. At 3, 7, and 10 days post-infection, mice were subjected to transient middle cerebral artery occlusion, followed by sacrifice 24 hours after reperfusion for subsequent analysis. The anticoagulant drug acetylsalicylic acid was administered as treatment 1 day before transient middle cerebral artery occlusion. RESULTS: Our research demonstrated a time-dependent deterioration of cerebral ischemia after transient middle cerebral artery occlusion, resulting in increased infarct volume and a worsened neurological outcome at the propagation and inflammation phases of infection. Our observations revealed an elevation in procoagulant activity and an increase in thrombosis within the microvasculature after infection and stroke. This effect was attributed to an infection-mediated inflammatory milieu and accelerated neutrophil response. Upon infection, the release of increased neutrophil extracellular traps by neutrophils had detrimental consequences for transient middle cerebral artery occlusion development. Administration of acetylsalicylic acid or control antiviral therapy prevented the IAV-induced exacerbation of stroke and reduced brain damage by reducing NETosis and coagulation. CONCLUSIONS: These findings suggest that IAV infections enhance the systemic propensity for NETosis and foster a procoagulant state, thereby increasing the risk of cerebral damage and thrombosis following stroke. Targeting a combination of neutrophils and coagulation molecules simultaneously represents a promising treatment approach for clinical stroke.Keywords
This publication has 54 references indexed in Scilit:
- Neutrophil extracellular traps in influenza infectionHeliyon, 2023
- Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019The Lancet Neurology, 2021
- Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With InfluenzaJAMA Neurology, 2020
- Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infectionNature Communications, 2019
- The role of neutrophils in thrombosisThrombosis Research, 2018
- Influenza‐like illness as a trigger for ischemic strokeAnnals of Clinical and Translational Neurology, 2018
- Sex differences in immune responsesNature Reviews Immunology, 2016
- Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumoniaCellular & Molecular Immunology, 2016
- Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modalityCell Death & Differentiation, 2011
- High-dose aspirin is neuroprotective in a rat focal ischemia modelBrain Research, 2004